HIV

ViiV Receives EU Authorization for Juluca, the First 2-Drug, Once-Daily Pill for HIV
CP Wire
Mon, 05/21/18 - 09:08 am
ViiV Healthcare
Juluca
Europe
HIV
ViiV Receives EU Authorization for Juluca, the First 2-Drug, Once-Daily Pill for HIV
Mon, 05/21/18 - 08:31 am
ViiV Healthcare
HIV
Juluca
Regulators flag possible birth defect link to GSK's HIV drug
Yahoo/Reuters
Fri, 05/18/18 - 09:27 pm
GSK
HIV
Dolutegravir
birth defects
EMA
FDA
HIV Patients File Class Action and Personal Injury Lawsuits for California Patients Against Gilead
CP Wire
Wed, 05/9/18 - 09:27 am
Gilead Sciences
HIV
patients
TDF
TAF
California
GlaxoSmithKline's next-generation HIV battle against Gilead is already taking a toll on growth
Fierce Pharma
Sat, 04/28/18 - 12:13 pm
GSK
HIV
Biktarvy
Gilead Sciences
Triumeq
Tivicay
Gilead Receives Positive Opinion From CHMP on Combination HIV Drug Biktarvy
CP Wire
Fri, 04/27/18 - 11:39 am
Gilead Sciences
Biktarvy
HIV
Gilead Receives Positive Opinion From CHMP on Combination HIV Drug Biktarvy
Fri, 04/27/18 - 09:56 am
Gilead Sciences
Biktarvy
HIV
Look at our new launches, GSK urges, as its respiratory woes steal the limelight
Fierce Pharma
Wed, 04/25/18 - 10:38 pm
GSK
earnings
HIV
Shingrix
Gene editing shows promise in combating HIV reservoirs
Fierce Biotech
Sat, 04/21/18 - 12:47 pm
gene editing
HIV
Gilead: Did Biktarvy Kill The Sell Thesis?
Seeking Alpha
Tue, 03/27/18 - 09:54 am
Gilead Sciences
Biktarvy
HIV
Kite Pharma
3 Blockbuster Drug Launches to Watch In 2018
Motley Fool
Mon, 03/26/18 - 10:45 am
drug launches
Gilead Sciences
HIV
Biktarvy
Alnylam
Sanofi
Patisiran
Epidiolex
GW Pharma
GSK's two-drug HIV regimen wins European panel approval
Reuters
Sat, 03/24/18 - 09:05 am
GSK
HIV
Europe
CHMP
Juluca
Gilead Sciences' $14 Billion-Per-Year Threat
Motley Fool
Sun, 03/18/18 - 11:26 am
Gilead Sciences
GS-9620
GS-9722
HIV
Is Gilead Sciences Trying to Put Itself Out of Business?
Motley Fool
Wed, 03/14/18 - 09:31 pm
Gilead Sciences
hepatitis C
HIV
GS-9620
PGT121
Searching for HIV cure, Gilead’s new ‘shock and kill’ combo swats back lethal virus in monkeys
Endpoints
Tue, 03/6/18 - 09:38 am
HIV
Gilead Sciences
R&D
How Huge Is the Latest HIV Drug Approval for Gilead Sciences?
Motley Fool
Mon, 02/12/18 - 09:16 am
Gilead Sciences
HIV
FDA
Biktarvy
No more Mr Nice Guy: GlaxoSmithKline is coming out of its corner swinging
Endpoints
Thu, 02/8/18 - 11:18 am
GSK
R&D
Pharma CEOs
Emma Walmsley
Advair
Novartis
Sandoz
Gilead Sciences
HIV
A new pill to treat HIV just got approved — and it could shake up a $22 billion market
Business Insider
Thu, 02/8/18 - 09:30 am
HIV
Gilead Sciences
FDA
Bictegravir/emtricitabine/tenofovir alafenamide
Ready to take on Glaxo, Gilead's combo HIV med Biktarvy wins $6B FDA nod
Fierce Pharma
Wed, 02/7/18 - 10:32 pm
GSK
Gilead Sciences
HIV
FDA
Biktarvy
Aetna to pay $17 million over mailing that revealed HIV meds
Stat
Wed, 01/17/18 - 09:50 pm
Aetna
HIV
patients
privacy

Pages